Inhibitory effects of polyethers on human immunodeficiency virus replication. 1992

M Nakamura, and S Kunimoto, and Y Takahashi, and H Naganawa, and M Sakaue, and S Inoue, and T Ohno, and T Takeuchi
Department of Microbiology, Jikei University School of Medicine, Tokyo, Japan.

We examined the inhibitory activities of 10 polyether antibiotics on human immunodeficiency virus (HIV) type 1. These compounds caused concentration-dependent inhibition of HIV replication in primary infected cultures of human T-lymphoblastoid H9 cells. The ratio of 50% effective concentrations for cellular cytotoxicity (MTT assay) to antiviral activity (reverse transcriptase assay) was over 5. Anti-HIV activity was also observed in cultures of monocytic lineage U937 cells chronically infected with HIV.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004987 Ethers Organic compounds having two alkyl or aryl groups bonded to an oxygen atom, as in the formula R1–O–R2.
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

M Nakamura, and S Kunimoto, and Y Takahashi, and H Naganawa, and M Sakaue, and S Inoue, and T Ohno, and T Takeuchi
September 1993, Nihon rinsho. Japanese journal of clinical medicine,
M Nakamura, and S Kunimoto, and Y Takahashi, and H Naganawa, and M Sakaue, and S Inoue, and T Ohno, and T Takeuchi
January 2001, Microbiology and immunology,
M Nakamura, and S Kunimoto, and Y Takahashi, and H Naganawa, and M Sakaue, and S Inoue, and T Ohno, and T Takeuchi
June 1994, Chemico-biological interactions,
M Nakamura, and S Kunimoto, and Y Takahashi, and H Naganawa, and M Sakaue, and S Inoue, and T Ohno, and T Takeuchi
December 1988, Antiviral research,
M Nakamura, and S Kunimoto, and Y Takahashi, and H Naganawa, and M Sakaue, and S Inoue, and T Ohno, and T Takeuchi
February 1993, Molecular and cellular biochemistry,
M Nakamura, and S Kunimoto, and Y Takahashi, and H Naganawa, and M Sakaue, and S Inoue, and T Ohno, and T Takeuchi
June 1987, Antimicrobial agents and chemotherapy,
M Nakamura, and S Kunimoto, and Y Takahashi, and H Naganawa, and M Sakaue, and S Inoue, and T Ohno, and T Takeuchi
May 1999, Journal of virology,
M Nakamura, and S Kunimoto, and Y Takahashi, and H Naganawa, and M Sakaue, and S Inoue, and T Ohno, and T Takeuchi
October 1992, Antimicrobial agents and chemotherapy,
M Nakamura, and S Kunimoto, and Y Takahashi, and H Naganawa, and M Sakaue, and S Inoue, and T Ohno, and T Takeuchi
October 1987, Antimicrobial agents and chemotherapy,
M Nakamura, and S Kunimoto, and Y Takahashi, and H Naganawa, and M Sakaue, and S Inoue, and T Ohno, and T Takeuchi
January 1991, Annual review of microbiology,
Copied contents to your clipboard!